The Discounted Cash Flow (DCF) valuation of Abbott Laboratories (ABT) is 138.21 USD. With the latest stock price at 101.83 USD, the upside of Abbott Laboratories based on DCF is 35.7%.
Based on the latest price of 101.83 USD and our DCF valuation, Abbott Laboratories (ABT) is a buy. buying Abbott stocks now will result in a potential gain of 35.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.1% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 92.90 - 284.17 | 138.21 |
| Upside | -8.8% - 179.1% | 35.7% |